When we first began our work, we wanted to make a real impact and get involved in ushering in a new age of medical technology and progress. To that end, we have continued to grow as an organization every year, with the range of activities we do increasing along with our reach and influence. We have done a lot of things in the last few years since we first created our non-profit organization, and we would like to share some of those achievements with you here.
Since we launched our research fundraising project Lifespan.io in 2015, we have raised over $310,000 for breakthrough research and hosted the following successful crowdfunding campaigns:
We work to make high-impact collaborations with large-scale content creators on platforms like YouTube in order to inform and engage an ever-widening segment of the population on the topic of longevity research. We welcome the opportunity to work on more such initiatives; feel free to contact us if you are a content creator looking to produce well-informed videos on the subject of aging and life extension.
Why Age? Should We End Aging Forever? – Kurzgesagt
How to Cure Aging – During Your Lifetime? – Kurzgesagt
This Is How You Could Live An Extra 100 Years – Life Noggin
HOSTED A CONFERENCE IN NEW YORK CITY
In July 2018, we hosted the Ending Age-related diseases 2018 conference at the Cooper Union in the heart of New York City. The conference saw various industry experts and thought leaders come together for an action-packed day of research and biotech business talks and panels. Due to the success of the conference, we are planning to host a conference in New York every year from now on.
Keith Comito at Ending Age-Related Diseases 2018 — One Second, One Life | LEAF.
Dr. Aubrey de Grey at Ending Age-Related Diseases 2018 — Rejuvenation is Finally an Industry | LEAF.
The Current State of Aging Research — Ending Age-Related Diseases 2018 Panel | LEAF.
Translating Aging Research — Ending Age-Related Diseases 2018 Panel | LEAF.
REPORTING THE LATEST NEWS
Since January 2017, we have been reporting on the latest news and happenings in the aging research field. We interview the leading figures in rejuvenation biotech and aging research, report on the latest developments in the industry, create advocacy articles exploring the ethics and social issues of longer lives, and produce educational articles about the biology of aging.
Brought to you by Nicola Bagalà, the Rejuvenation Roundup is our monthly digest, which takes a look at the big news stories involving the industry and helps keep you informed of current developments in the aging research field. To accompany the monthly Rejuvenation Roundup, as of July, we also began to include a podcast version that takes a deeper look at some of the key stories from that particular month and is hosted by Ryan O’Shea of the Future Grind podcast. You can listen to the October episode below; for more, check out our Rejuvenation Roundup page.
Ryan O’Shea returns for another superb Rejuvenation Roundup Podcast, the accompanying podcast, and companion to this monthly article series. Nicola also brings you the latest news in detail covering a busy month in rejuvenation biotechnology here.
SUPPORTING POLICY CHANGE
We actively support and drive positive policy change in healthcare and the regulatory system. We work with other groups to engage with the FDA, support freedom of scientific knowledge, take part in community efforts to change policy, and interview lobbyists engaged with high level organizations such as the WHO.
BRINGING INVESTORS AND RESEARCHERS TOGETHER
In early 2018 we created the Longevity Investors Network (LIN), a project designed to create a network of investors interested in aging research as well as identifying promising startups working in the rejuvenation biotechnology space. The LIN meets every month and new companies working on therapies targeting the aging processes get to pitch to the network of investors, this brings researchers and investors together to help drive progress and funding.
THE REJUVENATION ROADMAP
In 2018 we launched the Rejuvenation Roadmap, a curated database tracking the various therapies targeting the aging processes in order to delay, prevent, or even reverse age-related diseases. The roadmap breaks down aging into nine categories of damage, known as the hallmarks, and shows which projects are targeting which hallmarks as well as how far along the clinical trial process they are. This is your one stop shop to see how things are progressing and how far we might be from these technologies being available.
If you would like to get involved directly with our work, support research projects, or help our org continue to grow by becoming a monthly Patron, you can find out how below.